key: cord-0954759-0kwtot1i
authors: Jones, Luke M.; Super, Elana H.; Batt, Lauren J.; Gasbarri, Matteo; Cheesman, Benjamin T.; Howe, Andrew M.; Coulston, Roger; Jones, Samuel T.
title: Broad-spectrum extracellular antiviral properties of Cucurbit[n]urils
date: 2022-03-15
journal: bioRxiv
DOI: 10.1101/2022.03.15.484424
sha: 6ccd8a74ae98b838f6eb3df4948fbfcf06c37b30
doc_id: 954759
cord_uid: 0kwtot1i

Viruses are microscopic pathogens capable of causing disease and are responsible for a range of human mortality and morbidity worldwide. They can be rendered harmless or destroyed with a range of antiviral chemical compounds. Cucurbit[n]urils (CB[n]s) are a macrocycle chemical compound existing as a range of homologues; due to their structure they can bind to biological materials, acting as supramolecular “hosts” to “guests”, such as amino acids. Due to the increasing need for a non-toxic antiviral compound, we investigated whether cucurbit[n]urils could act in an antiviral manner. We have found that certain cucurbit[n]uril homologues do indeed have an antiviral effect against a range of viruses, including RSV and SARS-CoV-2. In particular, we demonstrate that CB[7] is the active homologue of CB[n] mixtures, having an antiviral effect against enveloped and non-enveloped species. High levels of efficacy were observed with five-minute contact times across different viruses. We also demonstrate that CB[7] acts with an extracellular virucidal mode of action via host-guest supramolecular interactions between viral surface proteins and the CB[n] cavity, rather than via cell internalisation or a virustatic mechanism. This finding demonstrates that CB[7] acts as a supramolecular virucidal antiviral (a mechanism distinct from other current extracellular antivirals) demonstrating the potential of supramolecular interactions for future antiviral disinfectants.

Viruses are harmful, microscopic pathogens that replicate within host cells before being spread via 36 aerosols (coughs, sneezes), surface contamination, and/or infected biological fluids. The impact 37 each has varies, but they can be responsible for severe disease in human hosts, and disease outbreaks 38 (epidemics or pandemics), including the COVID-19 pandemic. Epidemics of viral diseases are also 39 increasing in frequency [1, 2], with associated costs in overall mortality, morbidity and economic 40 damage [3, 4] . Viruses themselves are composed of amino acids self-assembled into proteinaceous 41 shells -capsids -protecting the genome. The capsid may or may not be surrounded by a lipid 42 envelope. Regardless of envelope presence, all viruses sport attachment, or spike, proteins on their 43 surface for the purpose of adhering to and infecting host cells [5] . 45 To address the global threat posed by all viruses, there are three main interventions; vaccines, drugs 46 or disinfection. Chemical disinfectants (such as bleach and soaps) are often broad-spectrum and 47 have been deployed in a range of sprays, surface sanitisers, and hand-gels to prevent viral spread 48 [6]. However, many of these substances are highly cytotoxic and reactive, meaning their safe 49 applications can be limited. Less cytotoxic antiviral options have been previously studied, including 50 quaternary ammonium compounds [7, 8] , nanoparticles [9] [10] [11] , and polymers [12] [13] [14] . Each works 51 differently; some target the genetic material, some the viral capsid proteins, but all aim to inhibit 52 the virus such that it is no longer infectious. However, many remain toxic and so their range of use 53 is severely limited.

Macrocyclic compounds are frequently used as drug carriers [15, 16] , including as carriers for 56 antivirals [17, 18] . Additionally, due to their wide range of binding motifs, macrocycles offer the 57 potential to interact directly with viruses and inhibit infection. However, to date the use of 58 macrocycles as antivirals has been limited to modified macrocycles [19] , or their use via indirect We hypothosised that CB[n]s could bind directly to viruses via supramolecular interactions between 74 exposed surface proteins and the CB cavity, which would then inhibit infection. This inhibition 75 could be via reversible binding (virustatic) or may be irreversible if binding results in an irreversible 76 conformational change (virucidal). Both possibilities would inhibit infection, but only a virucidal 77 mechanism would lead to inactivation of the virus. This interaction is different to many other 78 extracellular antivirals, which largely function by mimicking cell-binding regions [19, 37, 38] 1:1 solution mixing with 0 and 0.5mg/ml CB[7], at higher levels (1mg/ml and above) no virus was 120 subsequently detected following incubation on cells (Figure 2 ). In addition, when virus was mixed 121 with CB[n], no virus was detected at 10mg/ml and above, although increasingly cellular damage, 122 perhaps due to undissolved solid particles, is observed at 20mg/ml and particularly 50mg/ml (see 123 ESI Figure S1 ). Although no viral presence was observed via confocal microscopy at 1mg/ml CB[7], TCID50 assays indicate some will still be present. This discrepancy can be explained through 125 the fact that 5mg/ml CB[7] is associated with an approximately 0.8-log reduction, which may be 126 enough to reduce the virus to a level that none was observed within the five blind-selected field-of-127 views of the monolayer. 

In order to confirm that inhibition is due to supramolecular binding of the CB to the virus, we In order to confirm that the mode of action of the CB was extracellular, DNA exposure assays were 157 performed. Such assays confirm the breakdown of the HSV-2 viral capsid and release of the genome 158 in a cell free environment. This is critical to show that the mechanism is not via disruption of 159 intracellular processes, such as viral replication pathways. The genome exposure assay includes a extracted viral DNA (that had initially been exposed to CB treatment). This had no effect on the Ct 175 value. It is important to note that this assay illustrates that cucurbiturils can interact virucidally with 176 viruses in a completely cell-free environment. cucurbiturils. In addition, both CB[7] and CB[n] seemed to be relatively ineffective when used in 205 a dose-response assay, with IC50 values of 10.40mg/ml and 0.78mg/ml respectively ( Figure 5D ). Human coronavirus are viruses of potential future pandemic concern. Therefore, we investigated Figure 7B shows that a formulation containing 5 mg/mL CB[n] leads to a 98.4% 249 reduction in feline coronavirus when added onto cotton inoculated with the virus (post-inoculation) 250 and a 99% reduction in murine norovirus (again post-inoculation). It was also observed, with 251 murine norovirus, that a 90% reduction in viral titre was achieved when the textile was pre-treated 252 with the CB[n] formulation ( Figure 7B ). In addition, further surface testing experiments were 253 performed with treated fabric (polyester-lycra) at an accredited laboratory. These ISO 18184 254 surface tests again found a reduction in viral titre when the fabric was pre-treated with 5mg/ml 255 CB[n]; feline coronavirus was reduced by 90% and murine norovirus by 62% ( Figure 7C ).

Page 9 of 17 257 Discussion 258 Through these results we have shown that cucurbit[n]urils are supramolecular broad-spectrum 259 virucidal antivirals. Using HSV-2 as a model system we confirmed antiviral efficacy, dose effect, 260 and a virucidal mechanism. Using guests with a strong binding affinity for the CB cavity we were 261 able to show that this effect is on account of direct cavity binding to the virus. We were then able 262 to broaden the range of viruses investigated to include several other species, including those of 263 significant human-health concern, such as RSV and SARS-CoV-2, again confirming an antiviral Guest-host Chemistry Assay 332 CB[7] powder stock was mixed with adamantylamine in a 1:1 molar ratio and resuspended at 333 50mg/ml in sterile dH2O. Samples from this solution were then diluted further to form stocks of 334 50mg/ml, 20mg/ml, 10mg/ml, 5mg/ml and 0.5mg/ml.

Dose-Response Assays 337 Cells were seeded at 170,000/ml, with 500µl of cell and media mixture added to each well of a 24 338 well plate (Corning, NY, USA). They were incubated at 37°C overnight or until cells were 90-339 100% confluent. Sterile Eppendorf tubes were then prepared containing 570µl of antiviral material 340 mixed with DMEM to provide the desired concentration of antiviral. A 1:100 dilution of virus stock 341 was also prepared; 30µl of this diluted virus stock was added to each Eppendorf containing 570µl 342 of antiviral/media mix. An addition Eppendorf tube was also prepared containing just 570µl 343 DMEM plus 30µl diluted virus stock to act at the non-treatment control (NTC). Eppendorfs mix was added to wells A3 and A4, and 50µl from the 1:2000 virus-antiviral mix was added to 364 wells A5 and A6. 50µl from these wells was then serially diluted down the plate to row G. In well 365 H1, 50µl of the originally incubated virus plus antiviral stock was added, resuspended, and serially 366 diluted to well H6. This process was repeated for the non-treatment control in wells A7-A12. The 367 plate was then incubated for one hour at 37°C. All medium was then discarded and replated with 368 100µl of methylcellulose DMEM. The plate was then incubated at 37°C until visible plaques were 369 formed, before being stained with crystal violet to allow plaque-counting. Buffer. Samples were briefly vortexed and incubated at 56°C for 15 minutes. 250μL molecular 389 grade ethanol (Merck Life Sciences) was then added to each sample before brief vortexing and 390 incubation for 5 minutes at room temperature. Samples were then added to a Viral Spin Column in 391 a collection tube before being centrifuged in a benchtop microcentrifuge at 6800 × g for 1 minute 392 (all subsequent centrifugation steps assume this speed unless otherwise specified). Flow-through 393 was discarded and 500μL Wash Buffer (WII) was added, before being centrifuged for 1 minute.

Flow-through was discarded and another 500µl of Wash Buffer added to each sample, before being 395 centrifuged for one minute. The spin column was then centrifuged in a clean collection tube for 1 396 minute to remove any residual Wash Buffer (WII). Each spin column was then placed in a collection 397 tube and genetic material eluted with 50μL sterile Rnase-free water. Samples were then incubated 398 at room temperature for 1 minute before being centrifuged for 1 minute to elute nucleic acids.

Purified viral DNA was stored at -80°C before being amplified in qPCR. Additional textile testing was carried out on polyester-lycra samples. In these instances, 474 impregnated AqFresh textile was prepared by immersing samples of polyester-lycra in a 5 wt% 475 AqFresh suspension in water (1L in 3L beaker) for 10 minutes while mixing at 300 rpm using a 

492 2. Nandy, A. and S. Basak, Viral epidemics and vaccine preparedness

The economics of viral outbreaks

The role of cellular adhesion molecules in virus attachment and entry

Sanitizing agents for virus inactivation and disinfection. View

Repurposing quaternary ammonium compounds as potential treatments 503 for COVID-19

New quaternary ammonium camphor derivatives and their antiviral 505 activity, genotoxic effects and cytotoxicity

Antiviral activity of algae biosynthesized silver and gold 508 nanoparticles against Herps Simplex (HSV-1) virus in vitro using cell-line culture 509 technique

Delivery of antiviral small interfering RNA with gold nanoparticles 511 inhibits dengue virus infection in vitro. The Journal of general virology

Investigation of the antiviral properties of copper iodide 514 nanoparticles against feline calicivirus

Dendrimers and antivirals: a review. Current 517 Drug Targets-Infectious Disorders

Antiviral mechanism of polyanionic carbosilane dendrimers 519 against HIV-1. International journal of nanomedicine

Nucleic acid polymers: broad spectrum antiviral activity, antiviral 521 mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection

Macrocyclic compounds for drug and gene delivery in immune-modulating 524 therapy. International journal of molecular sciences

Biotechnological applications of cyclodextrins. 528 Biotechnology advances

Antiviral activity of macrocyclic polyethers and their complexes with 530 the alkaline metal salts of N-phosphorylated amides and thioamides. Pharmaceutical 531 chemistry journal

Modified cyclodextrins as broad-spectrum antivirals. Science advances

Cholesterol depletion of human immunodeficiency virus type 1 and 535 simian immunodeficiency virus with β-cyclodextrin inactivates and permeabilizes the 536 virions: evidence for virion-associated lipid rafts

Cucurbiturils and related macrocycles

Controlling factors in the synthesis of cucurbituril and its homologues. The 541 Journal of organic chemistry

New cucurbituril homologues: syntheses, isolation, characterization, and 545 X-ray crystal structures of cucurbit [n] uril (n= 5, 7, and 8)

Deep inside cucurbiturils: physical properties and 548 volumes of their inner cavity determine the hydrophobic driving force for host-guest 549 complexation

Transfer Interactions in Cucurbit [10] uril

Selective inclusion of a hetero-guest pair in a molecular host: formation 554 of stable charge-transfer complexes in cucurbit [8] uril. Angewandte Chemie 555 International Edition

The potential of cucurbit [n] urils in drug delivery

Activation and Stabilization of Drugs by 559

Supramolecular pKa Shifts: Drug-Delivery Applications Tailored for Cucurbiturils

Cucurbituril as a versatile tool to tune the functions of proteins

Cucurbituril-assisted Supramolecular Polymeric Hydrogels, 564 in Cucurbituril-based Functional Materials

Cucurbit [8] uril-derived graphene hydrogels

The formation of cucurbituril 568 complexes with amino acids and amino alcohols in aqueous formic acid studied by 569 calorimetric titrations

Molecular recognition properties of acyclic 571 cucurbiturils toward amino acids, peptides, and a protein

Molecular recognition of insulin by a synthetic receptor

Cucurbit [7] uril as a Broad-Spectrum Antiviral Agent against Diverse 576 RNA Viruses

One-pot gram-scale synthesis of virucidal heparin-mimicking polymers 578 as HSV-1 inhibitors

Broad-spectrum non-toxic antiviral nanoparticles with a virucidal 580 inhibition mechanism

Comparison of the antiviral effect of solid-state copper and silver 582 compounds

Antiviral surfaces and coatings and their mechanisms of action

Cucurbituril chemistry: a tale of supramolecular success

Cucurbit [6] uril: a possible host for noble gas 590 atoms

Scope of amino acid recognition by cucurbit [8] uril. 592 Journal of Inclusion Phenomena and Macrocyclic Chemistry

New ultrahigh affinity host− guest complexes of cucurbit [7] uril 594 with bicyclo [2.2. 2] octane and adamantane guests: Thermodynamic analysis and 595 evaluation of m2 affinity calculations

Synthesis and biological activity of adamantane derivatives

Viral inhibiting activity of some adamantylamines

Synthesis and antiviral activities of novel gossypol derivatives

Complexation of ferrocene derivatives by the cucurbit [7] uril host: a 603 comparative study of the cucurbituril and cyclodextrin host families

Unusual electrochemical properties of the inclusion complexes 606 of ferrocenium and cobaltocenium with cucurbit [7] uril

Toxicological Information

Time-of-addition and temperature-shift assays 611 to determine particular step (s) in the viral life cycle that is blocked by antiviral substance 612 (s)

The authors would like to thank Francesco Stellacci at the Supramolecular NanoMaterials and 616

Interfaces Laboratory in Switzerland for his help with all the SARS-CoV-2 related studies. The 617 authors would also like to thank Prof. Pamela Vallely and Prof. Paul Klapper for their help with 618 supply of cell lines and viruses. The authors would also like to thank Dr

Trinh for generously providing bacterial DNA and associated primers. Finally, the authors would 620 also like to thank Dr

Funding 623 SMJ was funded by a Dame Kathleen Ollerenshaw Fellowship

LMJ was funded by an Innovate UK grant. AH, BC, and RC were partners on the same Innovate 625 UK grant

LB was funded by the BBSRC

MG was supported by National Center of Competence in Research (NCCR) Bio-Inspired Materials. Author contributions

LB performed experiments for Figures 1-6A. MG performed SARS-CoV-2 632 experiments for Figure 6B. BC, AH, RC commissioned testing for Figure 7